Cholic acid (Orphacol) - Laboratoires CTRS

Drug Profile

Cholic acid (Orphacol) - Laboratoires CTRS

Alternative Names: Orphacol

Latest Information Update: 31 May 2016

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Laboratoires CTRS
  • Class Choleretics; Cholic acids; Gallstone therapies; Small molecules
  • Mechanism of Action Cholesterol 7 alpha hydroxylase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Inborn genetic disorders
  • New Molecular Entity No

Highest Development Phases

  • Marketed Inborn genetic disorders

Most Recent Events

  • 31 May 2016 Launched for Inborn genetic disorders in Germany (PO) before May 2016
  • 12 Sep 2013 Registered for Inborn genetic disorders (inborn errors in primary bile acid synthesis) in European Union (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top